BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8406435)

  • 1. Founder effect in a Belgian-Dutch fragile X population.
    Buyle S; Reyniers E; Vits L; De Boulle K; Handig I; Wuyts FL; Deelen W; Halley DJ; Oostra BA; Willems PJ
    Hum Genet; 1993 Oct; 92(3):269-72. PubMed ID: 8406435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on the CGG repeat at the fragile X site in the non-retarded Japanese population and family suggest the presence of a subgroup of normal alleles predisposing to mutate.
    Arinami T; Asano M; Kobayashi K; Yanagi H; Hamaguchi H
    Hum Genet; 1993 Nov; 92(5):431-6. PubMed ID: 8244331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
    Zhong N; Ye L; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striking founder effect for the fragile X syndrome in Finland.
    Oudet C; von Koskull H; Nordström AM; Peippo M; Mandel JL
    Eur J Hum Genet; 1993; 1(3):181-9. PubMed ID: 8044645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of FMR-1 and associated microsatellite alleles in a normal Chinese population.
    Zhong N; Liu X; Gou S; Houck GE; Li S; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):417-22. PubMed ID: 7943010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes.
    Oudet C; Mornet E; Serre JL; Thomas F; Lentes-Zengerling S; Kretz C; Deluchat C; Tejada I; Boué J; Boué A
    Am J Hum Genet; 1993 Feb; 52(2):297-304. PubMed ID: 8094266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong founder effect for the fragile X syndrome in Sweden.
    Malmgren H; Gustavson KH; Oudet C; Holmgren G; Pettersson U; Dahl N
    Eur J Hum Genet; 1994; 2(2):103-9. PubMed ID: 8044655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of the fragile X syndrome mutation.
    Hirst MC; Knight SJ; Christodoulou Z; Grewal PK; Fryns JP; Davies KE
    J Med Genet; 1993 Aug; 30(8):647-50. PubMed ID: 8411050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X founder chromosomes in Italy: a few initial events and possible explanation for their heterogeneity.
    Chiurazzi P; Genuardi M; Kozak L; Giovannucci-Uzielli ML; Bussani C; Dagna-Bricarelli F; Grasso M; Perroni L; Sebastio G; Sperandeo MP; Oostra BA; Neri G
    Am J Med Genet; 1996 Jul; 64(1):209-15. PubMed ID: 8826478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus.
    Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G
    Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation.
    Snow K; Tester DJ; Kruckeberg KE; Schaid DJ; Thibodeau SN
    Hum Mol Genet; 1994 Sep; 3(9):1543-51. PubMed ID: 7833909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and stability of the fragile X premutation.
    Reiss AL; Kazazian HH; Krebs CM; McAughan A; Boehm CD; Abrams MT; Nelson DL
    Hum Mol Genet; 1994 Mar; 3(3):393-8. PubMed ID: 8012350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes.
    Haataja R; Väisänen ML; Li M; Ryynänen M; Leisti J
    Hum Genet; 1994 Nov; 94(5):479-83. PubMed ID: 7959680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype and AGG interspersion analysis of FMR1 alleles in a Croatian population: no founder effect detected in patients with fragile X syndrome.
    Dokić H; Barisić I; Culić V; Lozić B; Hećimović S
    Hum Biol; 2008 Oct; 80(5):581-7. PubMed ID: 19341325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.
    Eichler EE; Macpherson JN; Murray A; Jacobs PA; Chakravarti A; Nelson DL
    Hum Mol Genet; 1996 Mar; 5(3):319-30. PubMed ID: 8852655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of FMR1 (CGG)(n) alleles and DXS548-FRAXAC1 haplotypes in three European circumpolar populations: traces of genetic relationship with Asia.
    Larsen LA; Vuust J; Nystad M; Evseeva I; Van Ghelue M; Tranebjaerg L
    Eur J Hum Genet; 2001 Sep; 9(9):724-7. PubMed ID: 11571563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insert size and flanking haplotype in fragile X and normal populations: possible multiple origins for the fragile X mutation.
    Macpherson JN; Bullman H; Youings SA; Jacobs PA
    Hum Mol Genet; 1994 Mar; 3(3):399-405. PubMed ID: 8012351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype analysis at the FRAXA locus in the Japanese population.
    Richards RI; Kondo I; Holman K; Yamauchi M; Seki N; Kishi K; Staples A; Sutherland GR; Hori T
    Am J Med Genet; 1994 Jul; 51(4):412-6. PubMed ID: 7943009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of founder chromosomes in fragile X syndrome.
    Richards RI; Holman K; Friend K; Kremer E; Hillen D; Staples A; Brown WT; Goonewardena P; Tarleton J; Schwartz C
    Nat Genet; 1992 Jul; 1(4):257-60. PubMed ID: 1302021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.